FindTrial
Sign In

Study to Assess and Compare the Efficacy of two common second generation supraglottic airway devices against aspiration of orally instilled dye.

COMPARATIVE STUDY OF AMBU-AURAGAIN AND i-GEL AS A BARRIER TO DYE PLACED IN THE OROPHARYNX

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/018983
Enrollment
60
Registered
2019-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K802- Calculus of gallbladder without cholecystitis

Interventions

Intervention1: airway device insertion: using Ambu AuraGain airway device in set of patients undergoing elective surgery and i gel airway device in other set of patients and comparison of efficacy of

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status 1 and 2

Exclusion criteria

Exclusion criteria: 1.Neurological or psychiatric disorders. 2.Patient needing their airway secured before administering muscle relaxant. 3.Any contraindications for using SAD. 4.History of gastro esophageal reflux disease. 5.Allergy to any of the study drugs. 6.Pregnant patients

Design outcomes

Primary

MeasureTime frame
Incidence of dye leak under the bowl of Supraglottic Airway Device.Timepoint: at the start and at the end of procedure—

Secondary

MeasureTime frame
1.Fiberscopic glottic view. 2.Oropharyngeal leak pressure. 3.Gastric aspiration of dye.Timepoint: at the start and at the end of procedure—

Countries

India

Contacts

Public Contactmohammed jaffer sherif

Maulana Azad medical College

drsherifmbbs@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026